The AI-enabled non-invasive, cuffless, continuous blood pressure monitor and diagnostic offers a tool in the diagnostic management of hypertension. It adds to the wearable platform’s previously cleared cardiopulmonary diagnostics. The FDA cleared it as software as a medical device (SaMD).
SimpleSense captures and analyzes more than 85 unique biomarker data points. It ranges across the heart, lungs, hemodynamic and central vascular system. The platform provides continuous, time-synchronous biometric data.
According to Nanowear, SimpleSense aggregates millisecond-by-millisecond cardiopulmonary assessments. This assists medical professionals in remote patient management. With proprietary nanosensors and algorithms, SimpleSense could offer an alternative to first-l…